Viewing Study NCT00259103

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:13 PM
Ignite Modification Date: 2026-02-01 @ 12:19 PM
Study NCT ID: NCT00259103
Status: COMPLETED
Last Update Posted: 2014-05-07
First Post: 2005-11-15
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Recombinant Human Relaxin (rhRlx) in Pregnant Women Scheduled for Induction of Labor
Sponsor: Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Labor, Induced View
Keywords:

Keywords

Keyword Brief Keyword Text View
None relaxin View
None pregnancy View
None cervical ripening View
None normal pregnancy at least at 40 weeks of gestation View